| 沙利度胺减轻肿瘤患者伊立替康化疗毒性及改善生活质量的临床观察 |
| |
| 引用本文： | 陈龙佩,陈天然,颜 芳,傅 强.沙利度胺减轻肿瘤患者伊立替康化疗毒性及改善生活质量的临床观察[J].现代肿瘤医学,2021,0(19):3462-3465. |
| |
| 作者姓名： | 陈龙佩 陈天然 颜 芳 傅 强 |
| |
| 作者单位： | 海军军医大学附属上海长海医院肿瘤科，上海 200080 |
| |
| 基金项目： | National Natural Science Foundation of China(No.81572415）;国家自然科学基金面上项目（编号:81572415） |
| |
| 摘 要： | 目的:探讨沙利度胺能否减轻肿瘤患者伊立替康化疗引起的恶心、呕吐等毒副反应。方法:纳入2016年01月至2019年10月间155例使用伊立替康化疗的晚期胃癌、食管癌及结直肠癌患者，分成对照组、沙利度胺组、解痉药组、阿普唑仑组。结果:沙利度胺组患者应用伊立替康化疗后SPIEGEL量表、SS-QOL 评分有显著提高（P＜0.05），化疗相关恶心、呕吐明显改善，这些患者的失眠率也明显改善（P＜0.05）。结论:沙利度胺能有效缓解使用伊立替康化疗的肿瘤患者化疗毒副反应，并可改善睡眠，提高生活质量。
|
| 关 键 词： | 化疗相关恶心呕吐 沙利度胺 伊立替康 SPIELET测量表 |
Clinical observation of thalidomide reducing irinotecan toxicity of chemotherapy and improving life quality in patients with tumor |
| |
| CHEN Longpei,CHEN Tianran,YAN Fang,FU Qiang.Clinical observation of thalidomide reducing irinotecan toxicity of chemotherapy and improving life quality in patients with tumor[J].Journal of Modern Oncology,2021,0(19):3462-3465. |
| |
| Authors: | CHEN Longpei CHEN Tianran YAN Fang FU Qiang |
| |
| Affiliation: | Department of Oncology，Changhai Hospital,Naval Medical University,Shanghai 200080,China. |
| |
| Abstract: | Objective:To investigate the efficacy of thalidomide on reducing nausea and vomiting caused by irinotecan in tumor patients.Methods:Inclusion of 155 patients with advanced gastric cancer,esophageal cancer and colorectal cancer who received irinotecan chemotherapy from January 2016 to October 2019 were included and divided into control group,thalidomide group,antispasmodics group,and alprazole Group.Results:The SPIEGEL scale and SS-QOL score of patients in the thalidomide group were significantly improved after irinotecan chemotherapy(P＜0.05).Chemotherapy-related nausea and vomiting and the insomnia rate were also significantly reduced(P＜0.05).Conclusion:Thalidomide can effectively alleviate toxic side effects of chemotherapy and improve sleep and the quality of life in patients treated with irinotecan. |
| |
| Keywords: | CINV thalidomide irinotecan SPIELET scale |
|
| 点击此处可从《现代肿瘤医学》浏览原始摘要信息 |
|
点击此处可从《现代肿瘤医学》下载全文 |
